The DOI matches its Crossref record; 130 of the 131 references it cites were found in a registry or an index.
Molecular Genetics of Late‐Onset Alzheimer's Disease
Open accessAbstract
Summary: Late‐onset Alzheimer's disease (AD) is a complex and multifactorial disease with the possible involvement of several genes. Apolipoprotein E (APOE), especially the APOE*4 allele, has been established as a strong susceptibility marker that accounts for nearly 30% of the risk in late‐onset AD. However, as the APOE*4 allele is neither necessary nor sufficient for the development of AD, it emphasizes the involvement of other genetic and/or environmental factors which, alone or in conjunction with APOE*4, can modify the risk of AD. Recently, genome‐wide linkage or linkage disequilibrium studies on late‐onset AD have provided informative data for the existence of multiple putative genes for AD on several chromosomes, with the strongest evidence on chromosomes 12, 10, 9 and 6. This paper attempts to review the current progress on the identification of additional genetic loci for late‐onset AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The APOE polymorphism is the most studied, successfully replicated, and well-established risk factor for AD where APOE*2 is the protective allele and APOE*4 is the risk allele as compared to APOE*3 [7–10].”
From Genome-wide analysis identifies novel loci influencing plasma apolipoprotein E concentration and Alzheimer’s disease risk (2023) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sørlie, T., Perou, C. M., Tibshirani, R. J., Aas, T., Geisler, S. B., Johnsen, H., Hastie, T. J., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 11,506
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Exploring the new world of the genome with DNA microarrays
Brown, P. O., & Botstein, D. (1999) · Nature Genetics · doi:10.1038/4462 · Cited by 2,430
Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052
Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818
Berge, K. E., Tian, H., Graf, G. A., Yu, L., Grishin, N. V., Schultz, J. R., Kwiterovich, P. O., Shan, B., Barnes, R., & Hobbs, H. H. (2000) · Science · doi:10.1126/science.290.5497.1771 · Cited by 1,645
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526
Research works printed but not linked: 4
- Holmans P., 2003, Evidence of interaction between susceptibility loci on chromosomes 1, 10 and 12 in late‐onset Alzheimer's disease (LOAD), Am J Hum Genet, 73, 184
- Roses A. D., 1995, Alzheimer's disease as a model of molecular gerontology, J NIH Res, 7, 51
- Stanton K. C., 2003, Further evidence of linkage of Alzheimer's disease on chromosome 12, Am J Hum Genet, 73, 471
- Xu P.‐T., 2002, Characterization and analyses of AD candidate genes P16 and MTAP on chromosome 9p21, Am J Hum Genet, 71, A490
Cited by
Sorted by citations
Review Article: Genetics of Alzheimer Disease
Bekris, L. M., Yu, C.-E., Bird, T. D., & Tsuang, D. W. (2010) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988710383571 · Cited by 1,029
Devi, L., Prabhu, B. M., Galati, D. F., Avadhani, N. G., & Anandatheerthavarada, H. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1469-06.2006 · Cited by 792
Epigenetic mechanisms in neurogenesis
Yao, B., Christian, K. M., He, C., Jin, P., Ming, G., & Song, H. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.70 · Cited by 406
Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice
Pedersen, W. A., McMillan, P. J., Kulstad, J. J., Leverenz, J. B., Craft, S., & Haynatzki, G. R. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.01.018 · Cited by 320
Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases
Migliore, L., & Coppedè, F. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.10.011 · Cited by 331
Chin, J., Palop, J. J., Puoliväli, J., Massaro, C., Bien-Ly, N., Gerstein, H., Scearce-Levie, K., Masliah, E., & Mucke, L. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2980-05.2005 · Cited by 312
Panula, P., Sallinen, V. J., Sundvik, M., Kolehmainen, J., Torkko, V., Tiittula, A., Moshnyakov, M., & Podlasz, P. (2006) · Zebrafish · doi:10.1089/zeb.2006.3.235 · Cited by 307
Grayson, B., Léger, M., Piercy, C., Adamson, L., Harte, M., & Neill, J. C. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.10.025 · Cited by 264
MicroRNA Expression in Alzheimer Blood Mononuclear Cells
Schipper, H. M., Maes, O. C., Chertkow, H. M., & Wang, E. (2007) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s361 · Cited by 246
Genetics of Alzheimer's Disease: A Centennial Review
Ertekin‐Taner, N. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.03.009 · Cited by 243
In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
Watt, G., & Karl, T. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00020 · Cited by 237
Sex Hormones and Cognition: Neuroendocrine Influences on Memory and Learning
Hamson, D. K., Roes, M., & Galea, L. A. M. (2016) · Comprehensive physiology · doi:10.1002/cphy.c150031 · Cited by 216
Devi, L., & Anandatheerthavarada, H. K. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.07.007 · Cited by 149
Li, Y., Nowotny, P., Holmans, P., Smemo, S., Kauwe, J. S. K., Hinrichs, A. L., Tacey, K. M., Doil, L. M., van Luchene, R., Garcia, V., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403535101 · Cited by 139
Biological function and clinical relevance of chromogranin A and derived peptides
D’Amico, M. A., Ghinassi, B., Izzicupo, P., Manzoli, L., & Baldassarre, A. D. (2014) · Endocrine Connections · doi:10.1530/ec-14-0027 · Cited by 138
Santoro, A., Balbi, V., Balducci, E., Pirazzini, C., Rosini, F., Tavano, F., Achilli, A., Siviero, P., Minicuci, N., Bellavista, E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012037 · Cited by 134
Genetics of Alzheimer’s Disease
Vilatela, M. E. A., López, M., & Yescas, P. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.10.017 · Cited by 138
Pathophysiology of Alzheimer's Disease
Imbimbo, B. P., Lombard, J., & Pomara, N. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.009 · Cited by 137
Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study
Lee, J. H. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1518 · Cited by 126
Genetic Factors in Alzheimer's Disease
Bird, T. D. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058027 · Cited by 122
Environmental and dietary risk factors in Alzheimer’s disease
Dosunmu, R., Wu, J., Basha, R. M., & Zawia, N. H. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.7.887 · Cited by 114
Cannabidiol for neurodegenerative disorders: A comprehensive review
Bhunia, S., Kolishetti, N., Yndart, A., Vashist, A., & Nair, M. G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.989717 · Cited by 121
Association of Low-Level Ozone with Cognitive Decline in Older Adults
Cleary, E. G., Cifuentes, M., Grinstein, G., Brugge, D., & Shea, T. B. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170658 · Cited by 109
Hardy, J. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330578 · Cited by 105
Genetics of Alzheimer's Disease. A Rapidly Evolving Field
Serretti, A., Olgiati, P., & Ronchi, D. D. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12108 · Cited by 105
Common Inflammatory Mechanisms in Lewy Body Disease and Alzheimer Disease
Mrak, R. E., & Griffin, W. S. T. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31812503e1 · Cited by 86
Association between APOE ε4 Allele and Vascular Dementia: The Cache County Study
Chuang, Y.-F., Hayden, K. M., Norton, M. C., Tschanz, J., Breitner, J. C. S., Welsh-Bohmer, K. A., Zandi, P. P., & for the Cache County Investigators (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000285166 · Cited by 81
Fan, J., Tao, W., Li, X., Li, H., Zhang, J., Wei, D., Chen, Y., & Zhang, Z. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051177 · Cited by 87
Less efficient pattern separation may contribute to age-related spatial memory deficits
Holden, H. M., & Gilbert, P. E. (2012) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2012.00009 · Cited by 85
Genetic heterogeneity of Alzheimer's disease: Complexity and advances
Lambert, J., & Amouyel, P. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.05.015 · Cited by 81
The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer’s disease
Karl, T., Garner, B., & Cheng, D. (2016) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000247 · Cited by 83
Genomics and Functional Genomics of Alzheimer's Disease
Kamboh, M. I. (2022) · Neurotherapeutics · doi:10.1007/s13311-021-01152-0 · Cited by 73
Self-citationGenetic Association of Neurotrophic Tyrosine Kinase Receptor Type 2 (NTRK2) With Alzheimer's Disease
Chen, Z., Simmons, M. S., Perry, R. T., Wiener, H. W., Harrell, L. E., & Go, R. C. P. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30607 · Cited by 71
Lee, S., Lemere, C. A., Frost, J. L., & Shea, T. B. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111025 · Cited by 68
Jackson, H. M., Soto, I., Graham, L. C., Carter, G. W., & Howell, G. R. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-831 · Cited by 66
Interleukin 18 gene polymorphisms predict risk and outcome of Alzheimer's disease
Bossù, P., Ciaramella, A., Moro, M. L., Bellincampi, L., Bernardini, S., Federici, G., Trequattrini, A., Macciardi, F. M., Spoletini, I., Iulio, F. D., et al. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.103242 · Cited by 64
Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures
Kamboh, M. I., Minster, R. L., Feingold, E., & DeKosky, S. T. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001775 · Cited by 62
Self-citationAlzheimer’s Disease – The Past, the Present and the Future
Botchway, B. O. A. (2017) · Science Journal of Clinical Medicine · doi:10.11648/j.sjcm.20170601.11 · Cited by 60
Pérez‐Palma, E., Bustos, B. I., Villamán, C., Alarcón, M. A., Ávila, M. E., Ugarte, G. D., Reyes, A. E., Opazo, C., Ferrari, G. V. D., Initiative, T. A. D. N., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095413 · Cited by 64
Desai, P. P., Nebes, R. D., DeKosky, S. T., & Kamboh, M. I. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.01.008 · Cited by 60
Self-citationGranins as disease-biomarkers: translational potential for psychiatric and neurological disorders
Bartolomucci, A., Pasinetti, G. M., & Salton, S. R. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.06.057 · Cited by 64
Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's disease
Bensemain, F., Hot, D., Ferreira, S., Dumont, J., Bombois, S., Maurage, C.-A., Huot, L., Hermant, X., Levillain, E., Hubans, C., et al. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002089 · Cited by 62
Novel behavioural characteristics of female APPSwe/PS1ΔE9 double transgenic mice
Cheng, D., Low, J. K., Logge, W., Garner, B., & Karl, T. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.11.046 · Cited by 61
Risk and protective factors for sporadic Alzheimer's disease.
Stožická, Z., Žilka, N., & Novák, M. (2007) · PubMed · Cited by 55
Kołodziej, D., Sobczak, Ł., & Łączkowski, K. Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137033 · Cited by 60
Apolipoprotein E υ4 Allele Frequency in Vascular Dementia
Davidson, Y. S., Gibbons, L., Purandare, N. B., Byrne, E. J., Hardicre, J., Wren, J., Payton, A., Pendleton, N., Horan, M. A., Burns, A. S., et al. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000092960 · Cited by 53
Age‐Related Inflammatory Diseases
Candore, G., Balistreri, C. R., Grimaldi, M. P., Vasto, S., Listı̀, F., Chiappelli, M., Licastro, F., Lio, D., & Caruso, C. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1386.008 · Cited by 51
Meta-analysis of APOE genotype and subarachnoid hemorrhage
Lanterna, L. A., Ruigrok, Y. M., Alexander, S. A., Tang, J., Biroli, F., Dunn, L., & Poon, W. S. (2007) · Neurology · doi:10.1212/01.wnl.0000267640.03300.6b · Cited by 52
Dementia with Lewy bodies: Definition, diagnosis, and pathogenic relationship to Alzheimer’s disease
Mrak, R. E., & Griffin, W. S. T. (2007) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a936 · Cited by 49
Early Molecular Changes in Alzheimer Disease: Can We Catch the Disease in its Presymptomatic Phase?
Wirz, K. T. S., Keitel, S., Swaab, D. F., Verhaagen, J., & Bossers, K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130920 · Cited by 47
Shea, T. B., & Chan, A. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13107 · Cited by 47
To die or not to die: DNA repair in neurons
McMurray, C. T. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.03.006 · Cited by 48
Corbo, R. M., Gambina, G., Ulizzi, L., Monini, P., Broggio, E., Rosano, A., & Scacchi, R. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000103866 · Cited by 43
Genome scan on Swedish Alzheimer's disease families
Sillén, A., Forsell, C., Lilius, L., Axelman, K., Björk, B. F., Onkamo, P., Kere, J., Winblad, B. G., & Graff, C. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001772 · Cited by 42
Öztürk, A., DeKosky, S. T., & Kamboh, M. I. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.024 · Cited by 41
Self-citationGenetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease
Ryman, D. C., Gao, Y., & Lamb, B. T. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.02.017 · Cited by 41
Early biomarkers for post-stroke cognitive impairment
Qian, L., Ding, L., Cheng, L., Zhu, X., Zhao, H., Jin, J., Guan, D.-N., Zhang, B., Chen, X., & Xu, Y. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6465-y · Cited by 40
Aslam, M. M., Fan, K.-H., Lawrence, E., Bedison, M. A., Snitz, B. E., DeKosky, S. T., Lopez, O. L., Feingold, E., & Kamboh, M. I. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02170-4 · Cited by 39
Self-citationDrug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease
Li, C., Ebrahimi, A., & Schluesener, H. J. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.09.002 · Cited by 44
Advances on the Understanding of the Origins of Synaptic Pathology in AD
Lacor, P. N. (2007) · Current Genomics · doi:10.2174/138920207783769530 · Cited by 40
D’Addario, C., Candia, S. B., Arosio, B., Bartolomeo, M. D., Abbate, C., Casè, A., Candeletti, S., Romualdi, P., Damanti, S., Maccarrone, M., et al. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.11.052 · Cited by 35
ABCA1 polymorphisms and Alzheimer's disease
Vrièze, F. W., Compton, D., Womick, M., Arepalli, S., Adighibe, O., Li, L., Pérez‐Tur, J., & Hardy, J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.02.010 · Cited by 34
Lee, J. H., Cheng, R., Santana, V., Williamson, J., Lantigua, R., Medrano, M. A., Arriaga, A., Stern, Y., Tycko, B., Rogaeva, E. A., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.11.1591 · Cited by 34
Bassett, S. S., Avramopoulos, D., Perry, R. T., Wiener, H. W., Watson, B., Go, R. C. P., & Fallin, M. D. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30350 · Cited by 32
Association study of the paraoxonase 1 gene with the risk of developing Alzheimer's disease
Chapuis, J., Boscher, M., Bensemain, F., Cottel, D., Amouyel, P., & Lambert, J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.021 · Cited by 32
Tobeh, N. S., & Bruce, K. D. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1259012 · Cited by 35
Differential Expression and miRNA–Gene Interactions in Early and Late Mild Cognitive Impairment
Brito, L. M., Ribeiro‐dos‐Santos, Â., Vidal, A. F., & de Araújo, G. S. (2020) · Biology · doi:10.3390/biology9090251 · Cited by 30
Age-at-onset linkage analysis in Caribbean Hispanics with familial late-onset Alzheimer’s disease
Lee, J. H., Barral, S., Cheng, R., Chacón, I. J., Santana, V., Williamson, J., Lantigua, R., Medrano, M. A., Jiménez‐Velázquez, I. Z., Stern, Y., et al. (2007) · Neurogenetics · doi:10.1007/s10048-007-0103-3 · Cited by 29
Apolipoprotein gene E4 allele promoter polymorphisms as risk factors for Alzheimer's disease
Parker, G. R., Cathcart, H., Huang, R., Lanham, I., Corder, E., & Poduslo, S. (2005) · Psychiatric Genetics · doi:10.1097/00041444-200512000-00009 · Cited by 28
Anandatheerthavarada, H. K., & Devi, L. (2007) · Reviews in the Neurosciences · doi:10.1515/revneuro.2007.18.5.343 · Cited by 28
Pritchard, A. L., Harris, J. M., Pritchard, C. W., Clair, D. S., Lemmon, H. A., Lambert, J., Chartier‐Harlin, M., Hayes, A., Thaker, U., Iwatsubo, T., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.016 · Cited by 29
Children of Persons With Alzheimer Disease
Jarvik, L. F., LaRue, A. A., Blacker, D., Gatz, M., Kawas, C. H., McArdle, J. J., Morris, J. C., Mortimer, J. A., Ringman, J. M., Ercoli, L. M., et al. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31816653ac · Cited by 31
Epigenetic Regulation of Neural Stem Cells in Developmental and Adult Stages
Kunoh, S., Nakashima, H., & Nakashima, K. (2024) · Epigenomes · doi:10.3390/epigenomes8020022 · Cited by 33
Association study of the Ubiquilin gene with Alzheimer's disease
Bensemain, F., Chapuis, J., Tian, J., Shi, J., Thaker, U., Lendon, C. L., Iwatsubo, T., Amouyel, P., Mann, D. M. A., & Lambert, J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.007 · Cited by 26
Association study of the PIN1 gene with Alzheimer's disease
Lambert, J., Bensemain, F., Chapuis, J., Cottel, D., & Amouyel, P. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.04.010 · Cited by 26
Alzheimer's disease: epidemiology
Mayeux, R. P. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01218-3 · Cited by 25
Risk Factors for Dementia in a Senegalese Elderly Population Aged 65 Years and Over
Toure, K., Coumé, M., Ndiaye, M. M., Zunzunegui, M. V., Bacher, Y., Diop, A. G., & Ndiaye, M. (2012) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000332022 · Cited by 24
Association of DAPK1 genetic variations with Alzheimer's disease in Han Chinese
Wu, Z., Zhang, W., Yu, J., Zhang, Q., Tian, Y., Lu, R.-C., Yu, N., Zhao-fu, C., & Tan, L. (2010) · Brain Research · doi:10.1016/j.brainres.2010.12.036 · Cited by 23
Association studies of transforming growth factor‐β1 and Alzheimer's disease
Dickson, M. R., Perry, R. T., Wiener, H. W., & Go, R. C. P. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30218 · Cited by 24
Current knowledge of chromosome 12 susceptibility genes for late-onset Alzheimer's disease
D’Introno, A., Solfrizzi, V., Colacicco, A. M., Capurso, C., Amodio, M., Todarello, O., Capurso, A., Kehoe, P. G., & Panza, F. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.020 · Cited by 23
Nutrition and Dementia: Are we Asking the Right Questions?
Shea, T. B., Rogers, E. J., & Remington, R. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112231 · Cited by 23
Subarachnoid hemorrhage: tests of association with apolipoprotein E and elastin genes
Kaushal, R. D., Woo, D., Pal, P., Haverbusch, M. A., Xi, H., Moomaw, C. J., Sekar, P., D, B. M. K. M., Kleindorfer, D., Flaherty, M. L., et al. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-49 · Cited by 23
Shi, J., Tian, J., Pritchard, A. L., Lendon, C. L., Lambert, J., Iwatsubo, T., & Mann, D. M. A. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1108-3 · Cited by 23
Genetic Epidemiology of Alzheimer Disease
Mayeux, R. P. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200607001-00008 · Cited by 25
Expanded high-resolution genetic study of 109 Swedish families with Alzheimer's disease
Sillén, A., Andrade, J., Lilius, L., Forsell, C., Axelman, K., Odeberg, J., Winblad, B. G., & Graff, C. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201946 · Cited by 22
Öztürk, A., Minster, R. L., DeKosky, S. T., & Kamboh, M. I. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30403 · Cited by 22
Self-citationBeyond Transgenic Mice: Emerging Models and Translational Strategies in Alzheimer’s Disease
Lopes, P. A., & Guil‐Guerrero, J. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125541 · Cited by 23
Freude, K., Pires, C., Hyttel, P., & Hall, V. J. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041402 · Cited by 21
Grünblatt, E., Reif, A., Jungwirth, S., Galimberti, D., Weber, H., Scarpini, E. A., Sauer, C., Wichart, I., Rainer, M. K., Huber, K. R., et al. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.03.017 · Cited by 19
No association of DAPK1 and ABCA2 SNPs on chromosome 9 with Alzheimer's disease
Minster, R. L., DeKosky, S. T., & Kamboh, M. I. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.006 · Cited by 19
Self-citationAge, Alzheimer's disease, and the big picture
Ganguli, M., & Rodríguez, E. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211001906 · Cited by 18
Emerging Medical Technologies and Emerging Conceptions of Health
Stempsey, W. E. (2006) · Metamedicine · doi:10.1007/s11017-006-9003-z · Cited by 17
Genetics of Late-Onset Alzheimer’s Disease: Progress and Prospect
Li, Y., & Grupe, A. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.12.1747 · Cited by 17
Boiocchi, C., Maggioli, E., Zorzetto, M., Sinforiani, E., Cereda, C., Ricevuti, G., & Cuccia, M. (2012) · Rejuvenation Research · doi:10.1089/rej.2012.1381 · Cited by 17
Raghavan, S. S., Iqbal, S., Ayyadurai, N., & Gunasekaran, K. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1871955 · Cited by 18
Polymorphic SERPINA3 prolongs oligomeric state of amyloid beta
Akbor, M. M., Kurosawa, N., Nakayama, H., Nakatani, A., Tomobe, K., Chiba, Y., Ueno, M., Tanaka, M., Nomura, Y., & Isobe, M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248027 · Cited by 17
The Genetics of Alzheimer’s Disease and Parkinson’s Disease
Bekris, L. M., Yu, C., Bird, T. D., & Tsuang, D. W. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_21 · Cited by 16
Association studies of 22 candidate SNPs with late‐onset Alzheimer's disease
Figgins, J. A., Minster, R. L., Demirci, F. Y., DeKosky, S. T., & Kamboh, M. I. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30851 · Cited by 15
Self-citationHeme Deficiency in Alzheimer’s Disease: A Possible Connection toPorphyria
Dwyer, B. E., Stone, M. L., Zhu, X., Perry, G. L., & Smith, M. A. (2006) · BioMed Research International · doi:10.1155/jbb/2006/24038 · Cited by 16
Panda, P. K., Patil, A. S., Patel, P., & Panchal, H. (2016) · Genomics Data · doi:10.1016/j.gdata.2016.01.003 · Cited by 15
Metadata
- Authors
- Kamboh, M. I.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Kamboh, M. Ilyas
- ORCID
- Kamboh, M. Ilyas
- Venue
- Annals of Human Genetics
- Publisher
- Wiley
- Published
- 2004-06-28
- Volume
- 68
- Issue
- 4
- Pages
- 381-404
- ISSN
- 0003-4800 (ISSN-L)
- 1469-1809
- OpenAlex
- W2137932456
- Cited by
- 170
- References
- 131
- Citations by year
- 2025: 4 · 2024: 2 · 2023: 4 · 2022: 2 · 2021: 6 · 2020: 4 · 2019: 1 · 2018: 1 · 2017: 5 · 2016: 7 · 2015: 4 · 2014: 7 · 2013: 6 · 2012: 12
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Annals of Human Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG 05-133, P50AG005133, AG13672, R01AG013672)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- late-onset Alzheimer's disease, apolipoprotein E, genetic susceptibility, genetic loci, genome-wide linkage analysis, linkage disequilibrium, complex diseases, genetic risk factors
- MeSH terms
- Alzheimer Disease, Apolipoproteins E, Humans, Genetic Linkage, Molecular Biology, Biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review